New LC/MS method for determination of progesterone in human plasma for therapeutic drug monitoring in pregnancy and gynecological disorders

Studia Universitatis Babes-Bolyai Chemia

Volumn 3, Issue , 2009, Pages 151-160

  Mihu, Dan ^a   Vlase, Laurian ^a   Imre, Silvia ^b   Mihu, Carmen M ^a   Achim, Marcela ^a   Muntean, Daniela Lucia ^b  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Human plasma; LC MS MS; Method validation; Progesterone

Indexed keywords

EID: 70350380130     PISSN: 12247154     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. R. C. Tuckey, Placenta, 2005, 26, 273.
2. H. Chang, S. Wu, J. Hu, M. Asami, S. Kunikane, J. Chromatogr. A., 2008, 1195, 44.
3. E. P. Kolodziej, J. L. Gray, D. L. Sedlak, Environ. Toxicol. Chem., 2003, 22, 2622.
4. E. P. Kolodziej, D. L. Sedlak, Environ. Sci. Technol., 2007, 41, 3514.
5. M. Kuster, M. J. Lopez de Alda, M. D. Hernando, M. Petrovic, J. Martin-Alonso, D. Barcelo, J. Hydrol., 2008, 358, 112.
6. M. J. Lopez de Alda, D. Barcelo, J. Chromatogr. A, 2000, 892, 391.
7. M. Sole, M. J. Lopez de Alda, M. Castillo, C. Porte, K. Ladegaard-Pedersen, D. Barcelo, Environ. Sci. Technol., 2000, 34, 5076.
8. B. J. Vanderford, R. A. Pearson, D. J. Rexing, S. A. Snyder, Anal. Chem., 2003, 75, 6265.
9. A. Yamamoto, N. Kakutani, K. Yamamoto, T. Kamiura, H. Miyakoda, Environ. Sci. Technol., 2006, 40, 4132.
10. D. Caruso, S. Scurati, O. Maschi, L. De Angelis, I. Roglio, S. Giatti, Neurochemistry International, 2008, 52, 560.
11. T. Higashi, A. Nagahama, Y. Mukai, K. Shimada, Biomed. Chromatogr., 2008, 22, 34.
12. P. E. Joos, M. V. Ryckeghem, Anal. Chem., 1999, 71, 4701.
13. Y. Yang, B. Shao, J. Zhang, Y. Wu, J. Ying, J. Chromatogr. B, 2008, 870, 241.
14. D. De Orsi, M. Pellegrini, S. Pichini, D. Mattioli, E. Marchei, L. Gagliardi, J. Pharm. Biomed. Anal., 2008, 48, 641.
15. B. Alvarez Sanchez, F. Priego Capote, J. Ruiz Jimenez, M. D. Luque de Castro, J. Chromatogr. A, 2008, 1207, 46.
16. N. Janzen, S. Sander, M. Terhardt, M. Peter, J. Sander, J. Chromatogr. B, 2008; 861, 117.
17. S. M. Zhang, S. R. Mada, S. Sharma, J. Pharm. Biomed. Anal., 2008, 48, 1174.
18. http://www.biocompare.com/ProductListings/29520/Progesterone-ELISA-EIA-Kits.html
19. The European Agency for the Evaluation of Medicinal Products, Note for Guidance on the Investigation of Bioavailability and Bioequivalence, CPMP/EWP/QWP/1401/98, 2001, London, UK, http://www.emea.europa.eu/pdfs/human/qwp/140198enfin.pdf
20. U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry. Bioavailability and Bioequivalence studies for orally administered drug products - general considerations, 2003, Rockville, USA, http://www.fda.gov/cder/guidance/5356fnl.pdf
21. U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry - Bioanalytical Method Validation, 2001, http://www.fda.gov/cder/guidance/4252fnl.pdf
22. L. Vlase, S. E. Leucuta, S. Imre, Talanta, 2008, 75(4), 1104.
23. L. Vlase, A. Leucuta, D. Farcau, M. Nanulescu, Biopharmaceutics & Drug Disposition, 2006, 27(6), 285.
24. L. Vlase, S. Imre, D. Muntean, S. E. Leucuta, Journal Of Pharmaceutical And Biomedical Analysis, 2007, 44(3), 652.
25. L. Vlase, D. Muntean, S. E. Leucuta, I. Baldea, Studia Universitatis Babes-Bolyai Chemia, 2009, 54(2), 43.
26. A. Butnariu, D. S. Popa, L. Vlase, M. Andreica, D. Muntean, S. E. Leucuta, Revista Romana de Medicina de Laborator, 2009, 15(2), 7.